NEWS

Brammer invests in commercial-ready gene therapies
OutSourcing-Pharma.com
The contract development and manufacturing organization (CDMO) said the site offers process development, clinical phase, and current Good Manufacturing Practices (cGMP) services for cell and gene therapies. “We are delighted to add an experienced …

Brammer invests in commercial-ready gene therapies
BioPharma-Reporter.com
The contract development and manufacturing organization (CDMO) said the site offers process development, clinical phase, and current Good Manufacturing Practices (cGMP) services for cell and gene therapies. “We are delighted to add an experienced …

Brammer invests in commercial-ready gene therapies
BioPharma-Reporter.com
The contract development and manufacturing organization (CDMO) said the site offers process development, clinical phase, and current Good Manufacturing Practices (cGMP) services for cell and gene therapies. “We are delighted to add an experienced …

Engineering human stem cells to model the kidney’s filtration barrier on a chip
EurekAlert (press release)
To build an in vitro model of the human glomerulus that could allow probing deeper into its function, as well as its vulnerabilities to disease and drug toxicities, researchers have been attempting to engineer human stem cells — that in theory can …

and more »

Engineering human stem cells to model the kidney’s filtration barrier on a chip
EurekAlert (press release)
To build an in vitro model of the human glomerulus that could allow probing deeper into its function, as well as its vulnerabilities to disease and drug toxicities, researchers have been attempting to engineer human stem cells — that in theory can …

and more »

How Things Work: Immunotherapy
CMU The Tartan Online
But did you know, thanks to recent research in the past few decades, that with the appropriate treatment, the immune system could be instrumental in curing cancer, one of the leading causes of death in America? Known as immunotherapy, the treatment has …
UCLA Researchers Design Process to Better Understand How Advanced Melanoma Adapts to ImmunotherapyNewswise (press release)

all 2 news articles »

New Antibody Armanezumab May Be Possible Therapeutic Strategy for ALS
ALS News Today
“We are still at the early stages of immunotherapy for neurodegenerative disorders and the field is advancing methodically. Humanized monoclonal antibodies have become very effective in treating various cancers, and we hope that disorders of the brain …